기업 정보 불러오는 중
Keep exploring
The themes Illumina is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
Highest-graded in Diagnostics and Research
Graded A or B and worth $2B or more: A first, then the largest.
TMOThermo Fisher Scientific Inc.US$259.2BA+
IDXXIdexx Laboratories Inc.US$55BA+
IQVIQVIA Holdings Inc.US$44.7BA
LHLabcorp Holdings Inc.US$30.2BA
DGXQuest Diagnostics IncUS$28.6BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026년 10월 21일CBGraded C, now B
MCKMckesson Corporation2026년 11월 4일BAGraded B, now A
CVSCVS Health Corp2026년 11월 4일BAGraded B, now A
EWEdwards Lifesciences Corporation2026년 11월 4일BAGraded B, now A
BIIBBiogen Inc.2026년 10월 28일BAGraded B, now A
어떻게 돈을 버는가
- Sequencing consumables73%
- Services and other16%
- Sequencing instruments11%
매출 비중은 quarter ended 2026-03-31 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.
경쟁 상대
무엇을 파는가6
NovaSeq X
A high-throughput DNA-sequencing machine used by customers that need to process large numbers of samples.
MiSeq i100
A lower-throughput DNA-sequencing machine for labs running smaller or more project-based batches.
NovaSeq 6000
A high-throughput DNA-sequencing machine that some customers continue to use alongside newer systems.
3개 더 보기
StrataMap Spatial
A sequencing-based workflow that helps researchers study biological activity in specific locations within tissue.
SomaScan and SomaSeq
Tools for measuring proteins and connecting protein measurements with genetic information.
Billion Cell Atlas
A large collection of data on how cells respond to genetic changes, sold to drug companies for biological research and drug discovery.
누가 사는가3
- Clinical laboratories and hospitals buy sequencing machines and supplies for testing, including cancer, inherited-disease and screening applications.
- Universities and research laboratories buy sequencing equipment and supplies to study genes, cells and biological processes.
- Drug companies buy sequencing-related services and biological data to support research and drug discovery.
무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가
사업이 기대고 있는 것
- 1Repeat consumables purchases depend on customers using Illumina machines and running samples on them.
- 2Clinical sequencing demand and purchases by large clinical customers are important sources of business growth.
- 3Instrument production depends on access to memory and other critical components, while freight costs affect expenses.
- 4Business in China is affected by restrictions associated with China's unreliable entity list.
잘못될 수 있는 일
- 1If clinical laboratories expand sequencing use more slowly or run fewer samples, demand for sequencing supplies could fall.
- 2Uncertain research funding can reduce purchases by universities and research customers; research and applied consumables were declining in the quarter discussed on the call.
- 3Higher memory and freight costs, or difficulty obtaining critical components, can increase costs and disrupt instrument supply.
Illumina, Inc. 소개
Illumina makes machines that read DNA and sells the chemicals and other supplies customers use to run samples on them. Hospitals and clinical laboratories use sequencing for applications such as cancer testing, inherited-disease testing and screening; researchers and drug companies use it to study biology and develop medicines. Illumina also sells tools for measuring proteins and provides biological data and related services.
- 본사
- San Diego, California
- 설립
- 1998
- 상장 시장
- Nasdaq
- 회계연도 종료
- Sunday nearest December 31
Illumina, Inc.이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.
